DILLY STEPHEN GEORGE 4
4 · Sierra Oncology, Inc. · Filed Mar 14, 2022
Insider Transaction Report
Form 4
DILLY STEPHEN GEORGE
DirectorCEO and President
Transactions
- Award
Stock Option (Right to Buy)
2022-03-14+165,000→ 165,000 totalExercise: $31.54Exp: 2032-03-14→ Common Stock (165,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the total shares subject to the option on March 14, 2023, and then 2.0833% of the shares subject to the option vest monthly thereafter, with 100% of the total shares subject to the option vested on March 14, 2026, subject to Reporting Person's provision of service to the Issuer on each vesting date.